-+ 0.00%
-+ 0.00%
-+ 0.00%

Molecular Partners Reports Nine Active Trial Sites And Ongoing Treatment In Phase 2 MP0317 Cholangiocarcinoma Study, With Data Update Expected In 2027 And Completion In 2028

Benzinga·07/16/2026 05:47:46
Listen to the news
  • Randomized Phase 2 study in front-line setting progressing well, with nine sites actively recruiting and patient treatment ongoing
  • Data update expected in 2027, with trial completion in 2028
  • Trial-in-progress poster to be presented at ESMO 2026 in October